First Advance in MDS for Decade: Luspatercept for Anemia First Advance in MDS for Decade: Luspatercept for Anemia

Luspatercept is now approved for use in the treatment of anemia in patients with myelodysplastic syndromes (MDS).FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news